#374 – Dr. Lana Feng, Co-Founder & CEO at Huma.Ai

Share This Post

Episode Details

Our Guest: Dr. Lana Feng, Co-Founder and CEO at Huma.AI

What you’ll get out of this episode:
 
  • Dr. Feng’s background
  • Overview of Huma.ai
  • Leveraging OpenAI’s generative technology to go beyond ChatGPT
  • What the future of clinical trials could look like
  • What’s next?

Watch

Listen

Read

Introduction

In a recent episode of the Slice of Healthcare podcast, host Jared S. Taylor had an engaging conversation with Dr. Lana Feng, the co-founder of Huma.AI. Dr. Feng shared her journey in the life sciences industry, the genesis of Huma.AI, and her vision for the future of clinical trials.

The Journey to Huma.AI

Dr. Feng, a life science expert with over twenty years of experience in precision medicine, has always been passionate about saving lives at scale. Her journey began with developing life-saving drugs, devices, and diagnostics, and she quickly became a pioneer in developing companion diagnostics for targeted cancer therapeutics. Her successful stint at an oncology company, Genostics, where she grew the pharma business from zero to forty-five million dollars in less than five years, was a testament to her expertise.

The Genesis of Huma.AI

The idea for Huma.AI was born out of a challenge that subject matter experts like Dr. Feng often face – getting answers out of data. Despite knowing what questions to ask, the lack of coding skills often creates a gap. Huma.AI aims to bridge this gap using natural language processing technology, transforming the experience of interrogating complex life sciences and healthcare data into a simple question-and-answer process.

Huma.AI Today

Huma.AI is a venture-backed, revenue-stage company with a robust customer base. It started as a natural language processing platform for life sciences, making the interrogation of complex data as easy as asking a question. The platform analyzes millions of documents across different data sources and finds applications in clinical development, medical affairs, real-world evidence, and post-market surveillance.

The Future of Clinical Trials

Dr. Feng envisions a future where AI plays a significant role in clinical development. With clinical trials becoming increasingly complex, AI can help interrogate unstructured data, guide trial design, patient selection criteria, and end goals. It can also help in patient recruitment and diversity, thereby accelerating the process of bringing life-saving drugs to market.

What’s Next for Huma.AI

The launch of their generative AI platform, which has already been independently validated and used by clients, marks the beginning of an exciting journey for Huma.AI. The company plans to transform the entire platform into a chat experience, opening up a new user interface and experience. The response from the industry has been overwhelmingly positive, and the team at Huma.AI is excited about what’s coming next.

Conclusion

Dr. Lana Feng’s journey and her work with Huma.AI are a testament to the transformative power of AI in the life sciences industry. As they continue to leverage AI for good, the future of clinical trials and healthcare looks promising. To learn more about Huma.AI, visit their website or connect with Dr. Feng on LinkedIn.

 


WORD FROM OUR SPONSORS:

Our sponsors for this episode are Sage Growth PartnersFlipMD by GoodRX and Quantum Health

 

Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners

GoodRX

GoodRx is a company that operates a platform and mobile application providing information and discounts on prescription drugs. It was founded in 2011 with the aim of helping consumers save money on their medication costs. GoodRx acts as a bridge between consumers, pharmacies, and pharmaceutical companies.

The primary function of GoodRx is to aggregate and compare prices of prescription drugs from various pharmacies across the United States. They gather pricing information for both generic and brand-name medications, allowing users to find the most affordable options available to them. The platform provides users with details about drug prices, discounts, and savings opportunities at different pharmacies in their local area.

For more information, please go to https://www.goodrx.com/ & follow FlipMD on social media – @goodrx

Quantum Health is an award-winning consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Launched in 1999, Quantum Health’s model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Visit: https://quantum-health.com/ and follow Quantum health on social media – @Quantum Health

To learn more about Huma.AI please use the links below:

Huma.AI LinkedInHuma.AI Website


Also, be sure to follow Slice of Healthcare on our social channels:

Website  – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share